The mosquito borne disease market comprises products such as mosquito repellent creams and oils, coils, vaporizers, sprays, aerosols, treated clothing, bed nets, anti-mosquito devices and others. Mosquito borne diseases can have serious health impacts including malaria, dengue fever, yellow fever, chikungunya, and zika virus. Access to affordable and effective mosquito borne disease prevention and diagnostic solutions is crucial due to the spread of mosquitoes to new areas.
The Global mosquito borne disease market is estimated to be valued at US$ 3.59 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Mosquito Borne Disease Market Size are Masimo, Medtronic Plc, Nihon-Kohden Corporation, GE Healthcare, Koninklijke Philips N.V., Hill-Rom Services, Inc.,Smiths Medical, Nonin, MICROTEK, OSI Systems, Inc. Honeywell International Inc., Promed Technology Co.Ltd., Beurer, Contec Medical Systems Co., Ltd., ChoiceMMed, CONMED Corporation, Stryker, Medline Industries, Inc., Curbell Medical Products, Inc., and Ecomed.
Key opportunities in the mosquito borne disease market include expanding distribution networks in developing regions and rural communities where there is a high risk of mosquito infestation. Technological advancements are taking place in diagnostic devices with the development of portable, non-invasive monitoring solutions enhanced by AI capabilities for early disease detection.
Market Drivers
The key drivers boosting the growth of the mosquito borne disease market are increasing incidence of mosquito borne diseases, rising awareness about prevention, growing demand for advanced monitoring and diagnostic solutions, and expansion of mosquito habitats due to climate change. According to the WHO, malaria infects over 200 million people annually worldwide. Early detection through rapid diagnostic testing allows for prompt treatment and reduces mortality. Demand for personal protective measures will rise with greater availability and affordability of effective products tailored to vulnerable populations and geographies.
Current Challenges in Mosquito Borne Disease Market
The mosquito borne disease market faces several challenges currently in effectively preventing and controlling such diseases. One of the major challenges is the development of insecticide resistance in mosquitoes against commonly used insecticides. Mosquitoes are able to develop resistance to insecticides quite rapidly requiring constant development of new products. Secondly, poor sanitation and lack of access to healthcare in many regions of the world enables the spread of such diseases. Thirdly, changing climate patterns are allowing the habitats and ranges of mosquitoes known to transmit diseases to expand to new geographical areas increasingly exposing more human population to risks. Concerted global efforts are required to overcome funding shortages, strengthen prevention programs through improved technologies and community outreach.
SWOT Analysis
Strength: Rapid technological advances are improving monitoring, diagnosis and treatment mechanisms. Preventive vaccines exist for diseases like Japanese encephalitis and research continues on others.
Weakness: Continued threat of emergence and re-emergence of mosquito borne diseases in new regions. Lack of adequate healthcare infrastructure and resources in certain endemic areas.
Opportunity: Rising awareness and preparedness levels are conducive to market growth. Increasing funding support for research especially for disease eradication.
Threats: Limited vaccine availability, emergence of drug/insecticide resistant strains and changing climate pose risks of resurgence.
North America and Europe currently account for over 45% of the total market value led by widespread penetration of advanced monitoring and preventive care technologies. However, the Asia Pacific region is expected to witness fastest growth during the forecast period due to rising incidence of dengue, malaria and chikungunya in many developing nations and increasing government initiatives for prevention and control. Countries like India, Indonesia, Brazil will be major drivers of future demand.
While the market is currently concentrated in developed regions, the greatest potential for future expansion lies in Africa and certain parts of Asia and Latin America experiencing high disease burden. Improved access to healthcare through government programs and philanthropic aid will be critical for tapping into the growth opportunities across emerging markets.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it